We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases

By LabMedica International staff writers
Posted on 17 Dec 2024

In a world facing a wide range of health challenges, from rapidly spreading viruses to chronic diseases and drug-resistant bacteria, the demand for fast, reliable, and user-friendly home diagnostic tests is more critical than ever. More...

Imagine a future where these tests can be conducted anywhere, by anyone, using a device as portable as a smartwatch. To make this a reality, microchips must be developed that can detect extremely low concentrations of viruses or bacteria in the air. New research shows that it is possible to design microchips capable of identifying multiple diseases from a single cough or air sample and to manufacture them at scale.

A team of researchers at NYU Tandon School of Engineering (Brooklyn, NY, USA) has introduced a groundbreaking technology using field-effect transistors (FETs), which are small electronic sensors that detect biological markers and convert them into digital signals. This technology presents an alternative to traditional color-based chemical tests, such as home pregnancy tests. The innovation allows for quicker results, simultaneous testing for multiple diseases, and instant data sharing with healthcare providers. FETs, widely used in modern electronics, are becoming essential in developing diagnostic tools. These miniature devices can be adapted as biosensors to detect specific pathogens or biomarkers in real-time, eliminating the need for chemical labels or lengthy laboratory procedures. By converting biological interactions into measurable electrical signals, FET-based biosensors provide a fast and versatile diagnostic platform.

Recent advancements have dramatically improved the sensitivity of FET biosensors, enabling them to detect concentrations as small as femtomolar levels, or one quadrillionth of a mole, by incorporating materials like nanowires, indium oxide, and graphene. However, despite their potential, FET sensors still face a significant hurdle: the challenge of detecting multiple pathogens or biomarkers simultaneously on a single chip. Existing methods, such as applying bioreceptors like antibodies to the FET’s surface, lack the precision and scalability needed for complex diagnostic tasks. To overcome this, the researchers are exploring new techniques to modify FET surfaces, allowing each transistor on a chip to detect a different biomarker, which would enable the parallel detection of multiple pathogens.

One promising solution is thermal scanning probe lithography (tSPL), a cutting-edge technology that allows for precise chemical patterning on a polymer-coated chip. This process enables the functionalization of individual FETs with different bioreceptors, such as antibodies or aptamers, at resolutions as fine as 20 nanometers, which matches the size of modern transistors. By enabling highly selective modifications of each transistor, this method could create FET-based sensors capable of detecting a wide array of pathogens on a single chip with exceptional sensitivity. In tests, FET sensors functionalized using tSPL demonstrated remarkable performance, detecting as few as 3 attomolar (aM) concentrations of SARS-CoV-2 spike proteins and identifying as few as 10 live virus particles per milliliter, all while distinguishing between various virus types, including influenza A.

The ability to accurately detect such minuscule amounts of pathogens with high specificity is a crucial step toward developing portable diagnostic devices for various settings, from hospitals to homes. As semiconductor technology continues to advance, it is becoming increasingly feasible to integrate billions of nanoscale FETs onto microchips. A universal, scalable approach for functionalizing FET surfaces with nanoscale precision would enable the creation of advanced diagnostic tools capable of detecting multiple diseases in real time with unmatched speed and accuracy, potentially revolutionizing modern healthcare. Following the study published in the journal Nanoscale, the research team is now focusing on developing wearable and home diagnostic devices that could detect illnesses.

“This study opens new horizons in the field of biosensing,” said NYU Tandon Professor Elisa Riedo. “Microchips, the backbone of smartphones, computers, and other smart devices, have transformed the way people communicate, entertain, and work. Similarly, today, our technology will allow microchips to revolutionize healthcare, from medical diagnostics, to environmental health.”


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.